A Prospective, With One Site, Open-label Not Controled Trial, for the Observation of Treatment With CIDOFOVIR 1%, 3 Nights Per Week, During 4 Weeks, of Anal Intraepithelial Neoplasia, High Level, in HIV+ Patients

Completed 20 enrolled Fundacion SEIMC-GESIDA

NaSingle-groupOpen-labelTreatment

Cidofovir could be an effective drug for the treatment of Anal Intraepithelial Neoplasia(AIN).

Evaluation	Drug	Modality	Dose	Route
Subject	CIDOFOVIR ANHYDROUS	Small molecule	1 %	Other
Subject	CIDOFOVIR ANHYDROUS	Small molecule	2 g	Other